To summarize, among DEGs, the expression of DDX41 in case sample (Ph + B-ALLIKZF1+/DDX41dm) was characterized by high-level expression of a set of genes involved in p53 signaling pathway when compared to Ph + B-ALLIKZF1+/DDX41− samples, whereas B cell receptor signaling pathway, PI3K-Akt signaling pathway, and NF-kappa B signaling pathway were differentially expressed compared to AML DDX41dm. Here, DDX41 is linked to acute myeloid leukemia.